CAS: 2230821-27-7
Gefitinib-Based PROTAC 3
CAS:2230821-27-7
Formula:
C47H57ClFN7O8S
Purity:
99%
Color and Shape:
Solid
Molecular weight:
934.514
Ref: IN-DA01JK78
| 1mg | 52.00 € | ||
| 5mg | 67.00 € | ||
| 10mg | 99.00 € | ||
| 25mg | 163.00 € | ||
| 50mg | 196.00 € | ||
| 100mg | 333.00 € |
Estimated delivery in United States, on Wednesday 9 Apr 2025
Ref: 54-BISN0057
| 1mg | 51.00 € | ||
| 5mg | 100.00 € | ||
| 10mg | 151.00 € | ||
| 25mg | 252.00 € | ||
| 50mg | 402.00 € | ||
| 100mg | 671.00 € |
Estimated delivery in United States, on Thursday 10 Apr 2025
Ref: 10-F986380
| 5mg | 185.00 € | ||
| 10mg | 294.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
Gefitinib-based PROTAC 3
CAS:2230821-27-7
Gefitinib-PROTAC 3 degrades EGFR in cancer cells; DC50s: 11.7 nM (HCC827) and 22.3 nM (H3255).
Formula:
C47H57ClFN7O8S
Purity:
97.29% - 98.25%
Color and Shape:
Solid
Molecular weight:
934.51
Ref: TM-T5437
| 2mg | 46.00 € | ||
| 5mg | 64.00 € | ||
| 10mg | 105.00 € | ||
| 25mg | 170.00 € | ||
| 50mg | 259.00 € | ||
| 100mg | 374.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Gefitinib-Based PROTAC 3
CAS:2230821-27-7
Please enquire for more information about Gefitinib-Based PROTAC 3 including the price, delivery time and …
Formula:
C47H57ClFN7O8S
Purity:
Min. 95%
Molecular weight:
934.51 g/mol
Ref: 3D-FPD82127
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
